Benfotiamine is a lipid-soluble synthetic derivative of thiamine, or vitamin B1, primarily used in the clinical management of diabetic neuropathy and other conditions associated with thiamine deficiency.… Read more





Benfotiamine is a lipid-soluble synthetic derivative of thiamine, or vitamin B1, primarily used in the clinical management of diabetic neuropathy and other conditions associated with thiamine deficiency. By acting as an antioxidant agent, it helps mitigate oxidative stress and mitochondrial dysfunction related to hyperglycemia. This category includes high-quality reference standards for Benfotiamine API, along with its relevant pharmacopeial and non-pharmacopeial impurities, such as degradation products and synthetic intermediates. These compounds are essential for laboratories conducting comprehensive impurity profiling, method validation, and stability testing to ensure therapeutic efficacy and regulatory compliance. Additionally, the collection features stable isotope labelled compounds, which are critical for providing reliable internal standards in quantitative analytical testing and quality control workflows. Each reference material is designed to support accurate identification and quantification throughout the drug development and manufacturing lifecycle.